LILAK vs PHI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LILAK · Liberty Latin America-C$9.16 ▼ 2.76%
PHI · PLDT$14.97 ▲ 0.94%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LILAK +59.9%
- PHI -27.9%
Head to head
| Metric | LILAK | PHI |
|---|---|---|
| Price | $9.16 | $14.97 |
| Change today | ▼ 2.76% | ▲ 0.94% |
| Market cap | $1.71B | $3.23B |
| Return, 3 months | +9.7% | -19.8% |
| Return, year to date | +80.7% | -25.6% |
| Return, 1 year | +61.9% | -28.0% |
| P/E (TTM) | – | 7.8 |
| P/B | 3.8 | 1.6 |
| P/E percentile vs own 5y | 21st | 12th |
| Dividend yield | – | 9.81% |
| Revenue growth (YoY, latest qtr) | +0.4% | +0.9% |
| Net profit growth (YoY) | -450.9% | -15.0% |
| Gross margin | 67.8% | 85.8% |
| Operating margin | 16.4% | 24.2% |
| Net margin | -4.2% | 12.0% |
| Return on equity | -34.6% | 21.4% |
| Analyst target vs. price | +9.2% | – |
| Analyst buy share | 0% | – |
| RSI (14) | 51 | 28 |
| 30-day volatility | 41.5% | 43.6% |
| Max drawdown, 1 year | -22.6% | -34.6% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Hold | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PHI is the largest of the group by market value.
- LILAK has returned the most over the past year.
- PHI is growing revenue fastest.
- PHI keeps the most profit per dollar of sales.
- LILAK has been the calmest stock over the last 30 days.